|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | |
| A61P 35/02 | |||
| A61P 35/04 | |||
| A61K 31/519 |
| (11) | Number of the document | 2638044 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11784977.8 |
| Date of filing the European patent application | 2011-11-08 | |
| (97) | Date of publication of the European application | 2013-09-18 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/069634 |
| Date | 2011-11-08 |
| (87) | Number | WO 2012/062745 |
| Date | 2012-05-18 |
| (30) | Number | Date | Country code |
| 412508 P | 2010-11-11 | US |
| (72) |
SCOTT, William, Johnston, US
MÖWES, Manfred, DE
BÖMER, Ulf, DE
MÖNNING, Ursula, DE
LIU, Ningshu, DE
|
| (73) |
Bayer Intellectual Property GmbH,
Alfred-Nobel-Strasse 10, 40789 Monheim,
DE
|
| (54) | ALKOXY-SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES |
| ALKOXY-SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES |